CLIENT NEWS
- InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-1921 December 2022
- Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD20 December 2022
- Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert20 December 2022
- Rentschler Biopharma awarded Chiesi Supplier Award19 December 2022
- Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform16 December 2022
- Carbios publishes first Sustainability Report and underscores commitment to circularity and environmental responsibilities15 December 2022
- ABIVAX TO ATTEND THE J.P. MORGAN 41ST ANNUAL HEALTHCARE CONFERENCE14 December 2022
- invIOs to present at Biotech Showcase14 December 2022
- Apogenix Enrolls First Patients in Pivotal Phase III Trial for the Treatment of Hospitalized COVID-19 Patients with Asunercept14 December 2022
- Spexis announces promising pre-clinical data with balixafortide in combination with various therapies on the market for treating B-cell lymphomas13 December 2022